← FDA Drug Approvals (Drugs@FDA)
CABAZITAXEL
NDA · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2019-11-22
Drug application
- FDA Application #
NDA207937- Application type
- New Drug Application
- Brand name
- CABAZITAXEL
- Generic name
- Cabazitaxel
- Active ingredients
- CABAZITAXEL
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- None (Tentative Approval)
- Sponsor
- FRESENIUS KABI USA
- First approval
- 2019-11-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown